After decades of stagnation in the drug treatment of schizophrenia, a handful of new therapies have raised hopes of improvement – but one of them has just failed a pair of phase 3 trials.

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

WEWAHITCHKA, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- UAV Corp. (OTC: UMAV) announced today that its subsidiary, Skyborne Technology, will conduct a scheduled inflation test of its DART SA-70 ...

Architecture reviews provide information about the status of software systems and identify risks. There are quick, meaningful ...

However, MoRTH has confirmed that this is only a test phase and no final decision has been made regarding nationwide adoption. While there's no replacement for FASTag as of now, the ministry did ...

"The project also fails the 'but for' test. Phase 1 is estimated to provide at least a 5.6% development yield in Year 3 and 6.8% in Year 10. These returns exceed a 4% market cap rate benchmark by at ...

China's domestically-developed large amphibious firefighting aircraft, the AG600 "Kunlong," received its type certificate from the Civil Aviation Administration of China, a milestone in China's ...

The Hardware Test Engineer will be responsible for the assembly, testing, and validation of hardware prototypes and electronic systems developed by the design team. This role focuses on ensuring the ...